Pathophysiology of Acute Decompensated Heart Failure

Heart Failure Clinics

Volumn 5, Issue 1, 2009, Pages 9-17

  Summers, Richard L ^a   Amsterdam, Ezra ^b  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute heart failure; Emergency medicine; Pathophysiology

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; DIURETIC AGENT; ENDOTHELIN 1; INOTROPIC AGENT; INTERLEUKIN 1; INTERLEUKIN 6; NEUROHORMONE; NORADRENALIN; RENIN; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

ACUTE DECOMPENSATED HEART FAILURE; ACUTE HEART FAILURE; ADRENERGIC SYSTEM; BODY FLUID; CHRONIC KIDNEY FAILURE; DEHYDRATION; DISEASE COURSE; DISEASE MARKER; DIURETIC ACTIVITY; HEART ATRIUM PRESSURE; HEART DISEASE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEMODYNAMICS; HORMONE ACTION; HUMAN; HYPERVOLEMIA; INFLAMMATION; NORADRENALIN BLOOD LEVEL; PATHOPHYSIOLOGY; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; VASOPRESSIN BLOOD LEVEL; VENOUS PRESSURE; VENOUS RETURN;

ARGININE VASOPRESSIN; CARDIAC OUTPUT; CYTOKINES; DEHYDRATION; HEART FAILURE; HEART FAILURE, DIASTOLIC; HEMODYNAMICS; HOMEOSTASIS; HUMANS; MODELS, CARDIOVASCULAR; MYOCARDIAL CONTRACTION; NATRIURETIC PEPTIDES; PULMONARY EDEMA; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; VENOUS PRESSURE;

EID: 56049092529     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2008.08.005     Document Type: Review

References (53)

1. Saba M.M., Ventura H.O., Saleh M., et al. Ancient Egyptian medicine and the concept of heart failure. J Card Fail 12 (2006) 416-421
2. Lutz J.E. A XII century description of congestive heart failure. Am J Cardiol 61 6 (1988) 494-495
3. Breckenridge A. William Withering's legacy-for the good of the patient. Clin Med 6 4 (2006) 393-397
4. Guyton A.C., Coleman T.G., and Granger H.J. Circulation: overall regulation. Annu Rev Physiol 34 (1972) 13-46
5. Guyton A.C. The systemic venous system in cardiac failure. J Chronic Dis 9 (1959) 465-475
6. Montani J.P., Adair T.H., Summers R.L., et al. A simulation support system for solving large physiological models on microcomputers. Int J Biomed Comput 24 (1989) 41-54
7. Bongartz L.G., Cramer M.J., Doevendans P.A., et al. The severe cardiorenal syndrome: Guyton revisited. Eur Heart J 26 (2005) 11-17
8. Mann D.L., and Bristow M.R. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111 21 (2005) 2837-2849
9. Braunwald E., and Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 102 4 (2000) IV14-IV23
10. Summers R.L. Rapid clinical assessment of hemodynamic profiles and targeted treatment of patients with acutely decompensated heart failure: wet and cold profile. Clin Cardiol 27 Suppl V (2004) V10-V11
11. Summers R.L. Cardiovascular emergencies: chapter 32: future diagnostics: impedance cardiography in the assessment and management of acute heart failure (2006), McGraw-Hill Companies, New York 357-63
12. Summers R.L. Emerging diagnostics: impedance cardiography in the assessment and management of acute heart failure. Critical Pathways in Cardiology 4 (2005) 134-139
13. Guyton A.C., Jones C.E., and Coleman T.G. Circulatory physiology: cardiac output and its regulation. (2nd edition) (1973), W.B. Saunders, Philadelphia
14. Hall J.E., Guyton A.C., and Mizelle H.L. Role of the renin-angiotensin system in control of sodium excretion and arterial pressure. Acta Physiol Scand Suppl 591 (1990) 48-62
15. Andrew P. Diastolic heart failure demystified. Chest 124 (2003) 744-753
16. Summers R.L., Kolb J.C., Woodward L.H., et al. Differentiating systolic from diastolic heart failure using impedance cardiography. Acad Emerg Med 6 7 (1999) 693-699
17. Carroll J.F., Summers R.L., Dzielak D.J., et al. Diastolic compliance is reduced in obese rabbits. Hypertension 33 (1999) 811-815
18. Summers R.L., and Kolb J.C. Left ventricular hypertrophy as a marker of diastolic dysfunction in patients with acute congestive heart failure. Eur J Emerg Med 9 4 (2002) 351
19. Summers R.L., and Montani J.P. Computer model of cardiac diastolic dynamics. Comput Cardiol 19 (1992) 697-700
20. Gaar Jr. K.A., Taylor A.E., and Owens L.J. Effect of capillary pressure and plasma protein on development of pulmonary edema. Am J Phys 213 1 (1967) 79-82
21. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311 13 (1984) 819-823
22. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 82 5 (1990) 1724-1729
23. Mann D.L., Kent R.L., Parsons B., et al. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85 2 (1992) 790-804
24. Adams J.W., Sakata Y., Davis M.G., et al. Enhanced Galpha q signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A 95 17 (1998) 10140-10145
25. Anand I.S., Ferrari R., Kalra G.S., et al. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 80 2 (1989) 299-305
26. Bader M., Jörg P., Ovidiu B., et al. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med 9 2 (2001) 76-102
27. Tan L.B., Jalil J.E., Pick R., et al. Cardiac myocyte necrosis induced by angiotensin II. Circ Res 69 5 (1991) 1185-1195
28. Francis G.S., Cohn J.N., and Johnson G. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation 87 Suppl. 6 (1993) V140-V148
29. Loskutoff D., and Quigley J. PAI-1, fibrosis, and the elusive provisional fibrin matrix. J Clin Invest 106 12 (2000) 1441-1443
30. Swedberg K., Eneroth P., Kjekshus J., et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 82 5 (1990) 1730-1736
31. Creager M., Faxon D., and Cutler S. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. J Am Coll Cardiol 7 4 (1986) 758-765
32. Summers R.L., and Montani J.P. Computer model of ANP-hemodynamic interactions. Comput Cardiol 18 (1991) 697-700
33. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 2 (1997) 509-516
34. Colucci W.S., Elkayam U., Horton D.P., et al. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N Engl J Med 343 4 (2000) 246-253
35. Maisel A.S., McCord J., Nowak R.M., et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the breathing not properly multinational study. J Am Coll Cardiol 1 11 (2003) 2010-2017
36. Wei C.M., Lerman A., Rodeheffer R.J., et al. Endothelin in human congestive heart failure. Circulation 89 4 (1994) 1580-1586
37. Bradham W.S., Bozkurt B., Gunasinghe H., et al. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res 53 4 (2002) 822-830
38. Torre-Amione G., Kapadia S., Benedict C., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27 5 (1996) 1201-1206
39. Francis S.E., Holden H., Holt C.M., et al. Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol 30 2 (1998) 215-223
40. Aukrust P., Ueland T., Lien E., et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83 3 (1999) 376-382
41. Aronson D., and Burger A.J. Neurohormonal prediction of mortality following admission for decompensated heart failure. Am J Cardiol 91 2 (2003) 245-248
42. Aronson D., and Burger A.J. Neurohumoral activation and ventricular arrhythmias in patients with decompensated congestive heart failure: role of endothelin. Pacing Clin Electrophysiol 26 3 (2003) 703-710
43. Milo O., Cotter G., Kaluski E., et al. Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. Am J Cardiol 92 2 (2003) 222-226
44. Chin. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: relationship to treatment and prognosis. Blood 14 6 (2003) 515
45. Mueller C., Laule-Kilian K., Christ A., et al. Inflammation and long-term mortality in acute congestive heart failure. Am Heart J 151 4 (2006) 845-850
46. Peschel T., Schonauer M., Thiele H., et al. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail 5 5 (2003) 609-614
47. Liang K., Williams A., and Greene E. Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 36 1 Suppl (2008) S75-S88
48. Peacock W.F., Allegra J., Ander D., et al. Management of acute decompensated heart failure in the emergency department. Congest Heart Fail 9 Suppl 1 (2003) 3-18
49. Rame J.E., Sheffield M.A., Dries D.L., et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J 142 (2001) 714-719
50. Shah M., Ali V., Lamba S., et al. Pathophysiology and clinical spectrum of acute congestive heart failure. Rev Cardiovasc Med Suppl (2001) 9-18
51. Burger A.J. A review of the renal and neurohormonal effects of B-type natriuretic peptide. Congest Heart Fail 11 1 (2005) 30-38
52. Cotter G., Felker G.M., Adams K.F., et al. The pathophysiology of acute heart failure-is it all about fluid accumulation?. Am Heart J. 155 (2008) 9-18
53. Cotter G., Metra M., Milo-Cotter O., et al. Fluid overload in acute heart failure-redistribution and other mechanisms beyond fluid accumulation. Eur J Heart Fail 10 2 (2008) 165-169